Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy
Allergy · 2026-08 · 81 (8) · 2898-2909
DOI: 10.1111/all.70250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, online erschienen am 11.02.2026. Verfasst von Amene Tesfaye Ayane und 12 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Research Group, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain. Hauptthemen laut MEDLINE: Amoxicillin, Mast Cells, Drug Hypersensitivity, Dendrimers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía, Spanish Ministry of Science, Innovation and Universities, European Union Next Generation EU/PRTR.
Abstract (Originalsprache)
Background
Amoxicillin (AX) is frequently implicated in immediate IgE‐mediated allergic reactions. Diagnosis is challenging, highlighting the need for new approaches enhancing in vitro sensitivity and specificity. Engineered nanostructures can mimic immunological recognition of hapten‐carrier conjugates, offering a strategy to improve diagnostic accuracy.
Methods
Dendrimeric Antigens (DeAns), with controlled size (1st–5th generation) and multivalent AX determinants (8–128 units, respectively), were synthesized for in vitro immunological evaluation. In vitro IgE recognition was studied by competitive radio‐immunoassay. Allergenic activity was evaluated in mouse bone marrow‐derived mast cells (MC) sensitized with mouse anti‐AX IgE monoclonal antibody and humanized RBL‐2H3 (huRBL‐2H3) and LUVA cells sensitized with sera from β‐lactam‐allergic subjects and tolerant controls, measuring degranulation in response to DeAns stimulation.
Results
Five different DeAns were obtained as pure compounds. All DeAns were recognized by AX‐sIgE. A clear size‐dependent activation pattern was observed in the three cell models: lower‐generation (1st–2nd) DeAns failed to induce degranulation, whereas DeAns of bigger size (3rd–5th generation) triggered significant, dose‐dependent activation. Notably, no activation was observed in tolerants and unsensitized cells or with blank dendrimers. In patient‐sera assays, the passive MC activation test (pMAT) with DeAns provided complete diagnostic discrimination, with activation restricted to AX‐allergic patients.
Conclusions
DeAns are effective platforms for investigating effector cell activation in AX allergy. By fine‐tuning structural attributes—size and multivalence—we reveal the promising utility of DeAns in pMAT that leverage commercial cell lines and patient sera. This approach could address key limitations of β‐lactam allergy diagnostics, enabling more reliable and standardized in vitro testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allergy Research Group, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain.
- Departamento de Química Orgánica, Universidad de Málaga, Málaga, Spain.
- Allergy Unit, Hospital Regional Universitario de Málaga-HRUM, Málaga, Spain.
- Departamento de Medicina y Dermatología, Universidad de Málaga, Málaga, Spain.
- Instituto de Investigación en Ciencias de la Alimentación (CIAL), CSIC-UAM, Madrid, Spain.
- Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.
ORCID-Profile: Amene Tesfaye Ayane, Maria Salas, Sara Benede, Maria J Rodriguez-Sanchez, Maria J Rodriguez-Sojo, Isabel M Jiménez-Sánchez, Gador Bogas, Ezequiel Perez-Inestrosa, Cristobalina Mayorga, Juan L Paris, Alba Rodríguez-Nogales, María J Torres, María I Montañez
Förderung
- Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía
- Spanish Ministry of Science, Innovation and Universities
- European Union Next Generation EU/PRTR
- Junta de Andalucía (FEDER funds)
- Instituto de Salud Carlos III (ISCIII)
- Andalusian Regional Ministry Health
- European Union's H2020
- European Commission
Zitieren
APA
Ayane, A. T., Salas, M., Benede, S., Rodriguez-Sanchez, M. J., Rodriguez-Sojo, M. J., Jiménez-Sánchez, I. M., Bogas, G., Perez-Inestrosa, E., Mayorga, C., Paris, J. L., Rodríguez-Nogales, A., Torres, M. J., & Montañez, M. I. (2026). Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy. Allergy, 81(8), 2898-2909. https://doi.org/10.1111/all.70250
Vancouver
Ayane AT, Salas M, Benede S, Rodriguez-Sanchez MJ, Rodriguez-Sojo MJ, Jiménez-Sánchez IM, et al. Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy. Allergy. 2026;81(8):2898-2909. doi:10.1111/all.70250
BibTeX
@article{Ayane2026,
author = {Ayane, Amene Tesfaye and Salas, Maria and Benede, Sara and Rodriguez-Sanchez, Maria J and Rodriguez-Sojo, Maria J and Jiménez-Sánchez, Isabel M and Bogas, Gador and Perez-Inestrosa, Ezequiel and Mayorga, Cristobalina and Paris, Juan L and Rodríguez-Nogales, Alba and Torres, María J and Montañez, María I},
title = {Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy},
journal = {Allergy},
year = {2026},
volume = {81},
number = {8},
pages = {2898--2909},
doi = {10.1111/all.70250}
}
EUVIMED